Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nutrients ; 13(2)2021 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-33572579

RESUMO

We examined, in a rat model of moderate environmental human exposure to cadmium (Cd), whether the enhanced intake of zinc (Zn) may protect against Cd-caused destroying the oxidative/antioxidative balance and its consequences in the brain. The intoxication with Cd (5 mg/L, 6 months) weakened the enzymatic (superoxide dismutase, glutathione peroxidase, catalase) and non-enzymatic (total thiol groups, reduced glutathione) antioxidative barrier decreasing the total antioxidative status and increased the concentrations of pro-oxidants (hydrogen peroxide, myeloperoxidase) in this organ and its total oxidative status. These resulted in the development of oxidative stress and oxidative modifications of lipids and proteins. The co-administration of Zn (30 and 60 mg/L enhancing this element intake by 79% and 151%, respectively) importantly protected against Cd accumulation in the brain tissue and this xenobiotic-induced development of oxidative stress and oxidative damage to lipids and proteins. Moreover, this bioelement also prevented Cd-mediated oxidative stress evaluated in the serum. The favorable effect of Zn was caused by its independent action and interaction with Cd. Concluding, the enhancement of Zn intake under oral exposure to Cd may prevent the oxidative/antioxidative imbalance and oxidative stress in the brain and thus protect against injury of cellular macromolecules in the nervous system.


Assuntos
Encéfalo/metabolismo , Cádmio/metabolismo , Exposição Ambiental/efeitos adversos , Estresse Oxidativo/efeitos dos fármacos , Oligoelementos/administração & dosagem , Zinco/administração & dosagem , Animais , Encéfalo/efeitos dos fármacos , Cádmio/administração & dosagem , Cádmio/toxicidade , Intoxicação por Cádmio/complicações , Intoxicação por Cádmio/metabolismo , Catalase/efeitos dos fármacos , Catalase/metabolismo , Água Potável , Glutationa Peroxidase/efeitos dos fármacos , Glutationa Peroxidase/metabolismo , Peróxido de Hidrogênio/metabolismo , Metabolismo dos Lipídeos/efeitos dos fármacos , Masculino , Modelos Animais , Oxirredução , Estresse Oxidativo/fisiologia , Peroxidase/metabolismo , Proteínas/metabolismo , Ratos , Ratos Wistar , Superóxido Dismutase/efeitos dos fármacos , Superóxido Dismutase/metabolismo , Fatores de Tempo , Oligoelementos/metabolismo , Oligoelementos/farmacologia , Zinco/metabolismo , Zinco/farmacologia
2.
Cytokine ; 106: 19-28, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29529595

RESUMO

Osteoprotegerin (OPG), receptor activator of NF-κB ligand (RANKL), and parathyroid hormone (PTH) play a central role in the regulation of bone turnover in chronic kidney disease (CKD), but their influence on bone mineral density (BMD) and strength remains unclear, particularly in children. We studied the clinical significance of OPG and RANKL in relation to PTH, femur weight, BMD, and bone biomechanical properties in growing rats after one month (CKD-1) and three months (CKD-3) of surgically-induced mild CKD. Gene expression of parathyroid hormone 1 receptor (PTH1R) and activating transcription factor 4 (ATF4), major regulators of anabolic PTH response in bone, was also determined. Serum PTH and bone PTH1R/ATF4 expression was elevated in CKD-3 compared with other groups, and it positively correlated with femur weight, BMD, and the biomechanical properties of the femoral diaphysis reflecting cortical bone strength. In contrast, bone RANKL/OPG ratios were decreased in CKD-3 rats compared with other groups, and they were inversely correlated with PTH and the other abovementioned bone parameters. However, the PTH-PTH1R-ATF4 axis exerted an unfavorable effect on the biomechanical properties of the femoral neck. In conclusion, this study showed for the first time an inverse association between serum PTH and the bone RANKL/OPG system in growing rats with mild CKD. A decrease in the RANKL/OPG ratio, associated with PTH-dependent activation of the anabolic PTH1R/ATF4 pathway, seems to be responsible for the unexpected, beneficial effect of PTH on cortical bone accrual and strength. Simultaneously, impaired biomechanical properties of the femoral neck were observed, making this bone site more susceptible to fractures.


Assuntos
Osso e Ossos/metabolismo , Osteoprotegerina/metabolismo , Hormônio Paratireóideo/metabolismo , Ligante RANK/metabolismo , Receptor Tipo 1 de Hormônio Paratireóideo/metabolismo , Uremia/metabolismo , Fator 4 Ativador da Transcrição/genética , Fator 4 Ativador da Transcrição/metabolismo , Animais , Fenômenos Biomecânicos , Densidade Óssea , Fêmur/metabolismo , Regulação da Expressão Gênica , Masculino , Tamanho do Órgão , Osteoprotegerina/sangue , Hormônio Paratireóideo/sangue , Ligante RANK/sangue , Ratos Wistar , Receptor Tipo 1 de Hormônio Paratireóideo/genética , Insuficiência Renal Crônica/sangue , Insuficiência Renal Crônica/diagnóstico por imagem , Insuficiência Renal Crônica/patologia , Uremia/sangue , Uremia/genética , Microtomografia por Raio-X
3.
Front Physiol ; 8: 836, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29163188

RESUMO

The diagnosis and treatment of bone disorders in patients with chronic kidney disease (CKD) represent a clinical challenge. CKD leads to mineral and bone complications starting early in the course of renal failure. Recently, we have observed the positive relationship between intensified central kynurenine turnover and bone strength in rats with subtotal 5/6 nephrectomy (5/6 Nx)-induced CKD. The aim of the present study was to determine the association between peripheral kynurenine pathway metabolites and bone strength in rats with 5/6 Nx-induced CKD. The animals were sacrificed 1 and 3 months after 5/6 Nx or sham operation. Nephrectomized rats presented higher concentrations of serum creatinine, urea nitrogen, and parathyroid hormone both 1 and 3 months after nephrectomy. These animals revealed higher concentrations of kynurenine and 3-hydroxykynurenine in the serum and higher gene expression of aryl hydrocarbon receptor (AhR) as a physiological receptor for kynurenine and AhR-dependent cytochrome in the bone tissue. Furthermore, nephrectomy significantly increased the number of osteoclasts in the bone without affecting their resorptive activity measured in serum. These changes were particularly evident in rats 1 month after 5/6 Nx. The main bone biomechanical parameters of the tibia were unchanged between nephrectomized and sham-operated rats but were significantly increased in older compared to younger animals. A similar trend was observed for geometrical parameters measured with calipers, bone mineral density based on Archimedes' method and image of bone microarchitecture obtained from micro-computed tomography analyses of tibial cortical bone. In nephrectomized animals, peripheral kynurenine levels correlated negatively with the main parameters of bone biomechanics, bone geometry, and bone mineral density values. In conclusion, our data suggest that CKD-induced elevated levels of peripheral kynurenine cause pathological changes in bone structure via AhR pathway. This finding opens new opportunities for the treatment/prevention of osteoporosis in CKD.

4.
Nutrients ; 9(6)2017 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-28587093

RESUMO

The hypothesis that the consumption of Aronia melanocarpa berries (chokeberries) extract, recently reported by us to improve bone metabolism in female rats at low-level and moderate chronic exposure to cadmium (1 and 5 mg Cd/kg diet for up to 24 months), may increase the bone resistance to fracture was investigated. Biomechanical properties of the neck (bending test with vertical head loading) and diaphysis (three-point bending test) of the femur of rats administered 0.1% aqueous chokeberry extract (65.74% of polyphenols) or/and Cd in the diet (1 and 5 mg Cd/kg) for 3, 10, 17, and 24 months were evaluated. Moreover, procollagen I was assayed in the bone tissue. The low-level and moderate exposure to Cd decreased the procollagen I concentration in the bone tissue and weakened the biomechanical properties of the femoral neck and diaphysis. Chokeberry extract administration under the exposure to Cd improved the bone collagen biosynthesis and femur biomechanical properties. The results allow for the conclusion that the consumption of chokeberry products under exposure to Cd may improve the bone biomechanical properties and protect from fracture. This study provides support for Aronia melanocarpa berries being a promising natural agent for skeletal protection under low-level and moderate chronic exposure to Cd.


Assuntos
Densidade Óssea/efeitos dos fármacos , Cádmio/toxicidade , Fêmur/efeitos dos fármacos , Photinia , Extratos Vegetais/farmacologia , Animais , Fenômenos Biomecânicos , Feminino , Fêmur/patologia , Frutas/fisiologia , Humanos , Extratos Vegetais/química , Ratos , Ratos Wistar
5.
PeerJ ; 5: e3199, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28439468

RESUMO

BACKGROUND: Disturbances in mineral and bone metabolism represent one of the most complex complications of chronic kidney disease (CKD). Serotonin, a monoamine synthesized from tryptophan, may play a potential role in bone metabolism. Brain-derived serotonin exerts a positive effect on the bone structure by limiting bone resorption and enhancing bone formation. Tryptophan is the precursor not only to the serotonin but also and primarily to kynurenine metabolites. The ultimate aim of the present study was to determine the association between central kynurenine metabolism and biomechanical as well as geometrical properties of bone in the experimental model of the early stage of CKD. METHODS: Thirty-three Wistar rats were randomly divided into two groups (sham-operated and subtotal nephrectomized animals). Three months after surgery, serum samples were obtained for the determination of biochemical parameters, bone turnover biomarkers, and kynurenine pathway metabolites; tibias were collected for bone biomechanical, bone geometrical, and bone mass density analysis; brains were removed and divided into five regions for the determination of kynurenine pathway metabolites. RESULTS: Subtotal nephrectomized rats presented higher serum concentrations of creatinine, urea nitrogen, and parathyroid hormone, and developed hypocalcemia. Several biomechanical and geometrical parameters were significantly elevated in rats with experimentally induced CKD. Subtotal nephrectomized rats presented significantly higher kynurenine concentrations and kynurenine/tryptophan ratio and significantly lower tryptophan levels in all studied parts of the brain. Kynurenine in the frontal cortex and tryptophan in the hypothalamus and striatum correlated positively with the main parameters of bone biomechanics and bone geometry. DISCUSSION: In addition to the complex mineral, hormone, and metabolite changes, intensified central kynurenine turnover may play an important role in the development of bone changes in the course of CKD.

6.
PLoS One ; 11(10): e0163526, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27711209

RESUMO

Chronic kidney disease (CKD) is associated with disturbances in bone strength and metabolism. The alterations of the serotonergic system are also observed in CKD. We used the 5/6 nephrectomy model of CKD to assess the impact of peripheral serotonin and its metabolite- 5-hydroxyindoleacetic acid on bone biomechanical properties and metabolism in growing rats. The animals were sacrificed one and three months after nephrectomy. Biomechanical properties were determined on two different bone types: the cortical bone of the femoral diaphysis using three-point bending test and the mixed cortico-trabecular bone by the bending test of the femoral neck. Biomechanical tests revealed preserved cortical bone strength, whereas work to fracture (W) and yield load (Fy) of mixed cortico-trabecular bone were significantly lower in CKD compared to controls. Serum activity of alkaline phosphatase (ALP), a bone formation marker, and tartrate-resistant acid phosphatase (TRACP 5b) reflecting bone resorption, were similar in CKD and controls. ALP was associated with lower femoral stiffness and strength, and higher displacements and W. TRACP 5b was inversely associated with cortical Fu and W. The elevated peripheral serotonergic system in CKD was: inversely associated with stiffness but positively related to the displacements and W; inversely associated with cortical Fy but positively correlated with this parameter in cortico-trabecular bone; inversely associated with ALP in controls but positively correlated with this biomarker in CKD animals. In conclusion, this study demonstrates the distinct effect of mild degree of CKD on bone strength in rapidly growing rats. The impaired renal function affects the peripheral serotonin metabolism, which in turn may influence the strength and metabolism of bones in these rats. This relationship seems to be beneficial on the biomechanical properties of the cortico-trabecular bone, whereas the cortical bone strength can be potentially reduced.


Assuntos
Osso Esponjoso/fisiopatologia , Osso Cortical/fisiopatologia , Ácido Hidroxi-Indolacético/metabolismo , Insuficiência Renal Crônica/metabolismo , Serotonina/metabolismo , Fosfatase Alcalina/sangue , Animais , Fenômenos Biomecânicos , Peso Corporal , Osso Esponjoso/metabolismo , Osso Cortical/metabolismo , Modelos Animais de Doenças , Fêmur/metabolismo , Fêmur/fisiopatologia , Masculino , Ratos , Ratos Wistar , Insuficiência Renal Crônica/sangue , Insuficiência Renal Crônica/fisiopatologia
7.
Planta Med ; 82(7): 621-31, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-27096624

RESUMO

Recently, we demonstrated in a rat model that consumption of a polyphenol-rich extract obtained from the berries of Aronia melanocarpa could protect from cadmium-induced disorders in bone turnover and changes in bone mineral status. The aim of this study was to investigate whether the osteoprotective effect of this extract is mediated by the oxidative defense system. Enzymatic and nonenzymatic antioxidants, total antioxidative and oxidative status, hydrogen peroxide, and markers of oxidative protein, lipid, and DNA damage were determined in bone tissue at the distal femoral epiphysis of female Wistar rats receiving 0.1 % aqueous A. melanocarpa extract (prepared from the lyophilized commercial extract containing 65.74 % of polyphenols) as the only drinking fluid and/or cadmium in the diet (1 and 5 mg/kg) for 3, 10, 17, and 24 months. The total oxidative and antioxidative status of the serum was also evaluated. The administration of A. melanocarpa extract provided significant protection from cadmium-induced oxidative stress in the bone and serum, and from lipid peroxidation and oxidative damage to the protein and DNA in the bone tissue. Numerous correlations were noted between indices of the oxidative/antioxidative bone status and markers of bone metabolism previously assayed in the animals receiving A. melanocarpa extract. The results allow the conclusion that the ability of A. melanocarpa extract to mediate the oxidative defense system and prevent oxidative modifications of protein, lipid, and DNA in the bone tissue plays an important role in its osteoprotective action under exposure to cadmium. The findings provide further evidence supporting our suggestion that chokeberry may be a promising natural agent for protection against the toxic action of cadmium in women chronically exposed to this metal.


Assuntos
Antioxidantes/farmacologia , Osso e Ossos/efeitos dos fármacos , Cádmio/toxicidade , Photinia/química , Extratos Vegetais/farmacologia , Polifenóis/farmacologia , Animais , Antioxidantes/isolamento & purificação , Dano ao DNA/efeitos dos fármacos , Feminino , Fêmur , Estresse Oxidativo/efeitos dos fármacos , Polifenóis/isolamento & purificação , Ratos , Ratos Wistar , Tíbia
8.
Chem Biol Interact ; 229: 132-46, 2015 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-25656917

RESUMO

It was investigated, in a female rat model of low and moderate lifetime human exposure to cadmium (Cd), whether polyphenols from Aronia melanocarpa berries (chokeberry; AMP) may offer protection from this heavy metal-induced disorders in bone metabolism. For this purpose, numerous indices of bone formation (osteocalcin, alkaline phosphatase, osteoprotegerin) and resorption (carboxy-terminal cross-linking telopeptides of type I collagen, soluble receptor activator of nuclear factor-κB ligand) in the serum and/or distal femur epiphysis (trabecular bone region), as well as bone mineral status (volumetric bone mineral density of the femur and content of mineral components, including calcium, in the bone tissue at the distal femur epiphysis) were evaluated in female Wistar rats that received a 0.1% aqueous extract of AMP, as the only drinking fluid (prepared from lyophilized extract by Adamed Consumer Healthcare), and/or Cd in diet (1 and 5mg/kg) for 3, 10, 17, and 24 months. Examination of the phytochemical profile of the aronia extract revealed high content of polyphenols (612.40 ± 3.33 mg/g), including anthocyanins, proanthocyanidins, phenolic acids, and flavonoids. Among detected compounds anthocyanins were identified as dominating. The exposure to Cd, dose- and duration-dependently, enhanced resorption and inhibited formation of the bone tissue resulting in its decreased mineralization. The administration of AMP under the exposure to 1 and 5 mgCd/kg diet provided important protection from this heavy metal-induced disturbances in the bone turnover and changes in the bone mineral status, and the beneficial impact of polyphenols resulted from their independent action and interaction with Cd. These findings suggest that consumption of Aronia melanocarpa polyphenols may play a role in prevention against female skeleton damage due to chronic exposure to Cd and that chokeberry represents the good natural plant candidate for further investigations of its prophylactic use under environmental exposure to this heavy metal.


Assuntos
Doenças Ósseas Metabólicas/induzido quimicamente , Doenças Ósseas Metabólicas/prevenção & controle , Osso e Ossos/efeitos dos fármacos , Cádmio/toxicidade , Polifenóis/uso terapêutico , Substâncias Protetoras/uso terapêutico , Animais , Densidade Óssea/efeitos dos fármacos , Doenças Ósseas Metabólicas/metabolismo , Doenças Ósseas Metabólicas/patologia , Osso e Ossos/metabolismo , Osso e Ossos/patologia , Feminino , Humanos , Photinia/química , Polifenóis/química , Substâncias Protetoras/química , Ratos , Ratos Wistar
9.
Exp Toxicol Pathol ; 65(5): 531-9, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22498023

RESUMO

This study investigated the influence of chlorfenvinphos (0.3 mg/kg bw/24 h corresponding to 0.02 LD50; orally by gastric gavage for 14 and 28 days) on lipid metabolism, and apoptotic and necrotic cells death in the brain of rats as the possible mechanism of neurotoxic action of organophosphate (OP) pesticides at low exposure. Total cholesterol (TCh), triglycerides (TG), phospholipids (PL), and free fatty acids (FFA) were determined and apoptotic, necrotic, and living cells were quantified in the brain. Moreover, the serum and brain acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) were assayed as biomarkers of neurotoxicity. The treatment with chlorfenvinphos increased (duration dependently) the concentrations of TCh and TG and the ratio of TCh/PL, and decreased PL concentration. The prevalence of apoptotic and necrotic cells increased and that of the living brain cells depressed (by 10%) already after 14 days of the exposure. The brain activities of AChE and BChE decreased by 12% and 15%, and by 18% and 25% after 14 and 28 days, respectively, whereas the serum activities of these enzymes were inhibited (by 24% and 18%, respectively) only after the longer treatment. The changes in lipid metabolism and distribution of the living, apoptotic, and necrotic brain cells correlated with AChE and BChE activities in the serum and brain. The results show that chlorfenvinphos may disturb lipid metabolism and induce apoptosis and necrosis in the brain even at the exposure not affecting the serum activities of cholinesterases, and causing only moderate inhibition of their brain activities. Based on the findings it can be concluded that low repeated exposure to OP pesticides may influence the nervous system through disrupting the lipid profile of the nervous tissue and decreasing the number of the nervous cells.


Assuntos
Apoptose/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Clorfenvinfos/toxicidade , Inseticidas/toxicidade , Metabolismo dos Lipídeos/efeitos dos fármacos , Acetilcolinesterase/sangue , Acetilcolinesterase/metabolismo , Animais , Encéfalo/enzimologia , Encéfalo/metabolismo , Encéfalo/patologia , Butirilcolinesterase/sangue , Butirilcolinesterase/metabolismo , Relação Dose-Resposta a Droga , Citometria de Fluxo , Masculino , Necrose/patologia , Ratos , Ratos Wistar
10.
J Trace Elem Med Biol ; 26(1): 46-52, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22100499

RESUMO

It was investigated whether the ability of zinc (Zn) to prevent cadmium (Cd)-induced lipid peroxidation may be connected with its impact on glutathione peroxidase (GPx) activity and selenium (Se) concentration. GPx and Se were determined in the serum, liver and kidney of the rats that received Cd (5 or 50 mg/L) or/and Zn (30 mg/L) in drinking water for 6 months in whose the protective Zn impact was noted (Rogalska J, Brzóska MM, Roszczenko A, Moniuszko-Jakoniuk J. Enhanced zinc consumption prevents cadmium-induced alterations in lipid metabolism in male rats. Chem Biol Interact 2009;177:142-52). Moreover, dependences between these parameters, and indices of lipid peroxidation (F(2)-isoprostane, lipid peroxides, oxidized low density lipoprotein cholesterol) as well as concentrations of Cd and Zn were estimated. The supplementation with Zn during the exposure to 5 mg Cd/L entirely antagonized the Cd-induced increase in GPx activity and Se concentration in the liver and kidney, but not in the serum. Zn administration during the treatment with 50 mg Cd/L totally or partially prevented from the Cd-caused decrease in GPx activity and Se concentration in the serum, liver and kidney. At the higher level of Cd exposure, GPx activity in the serum and tissues positively correlated with Se concentration. Moreover, numerous correlations were noted between GPx and/or Se and the indices of lipid peroxidation. The results indicate that the protective impact of Zn against the Cd-induced lipid peroxidation during the relatively high exposure might be connected with its beneficial influence on Se concentration and GPx activity in the serum and tissues, whereas this bioelement influence at the moderate exposure seems to be independent of GPx and Se.


Assuntos
Cádmio/toxicidade , Glutationa Peroxidase/metabolismo , Rim/metabolismo , Fígado/metabolismo , Selênio/metabolismo , Zinco/administração & dosagem , Animais , Suplementos Nutricionais , Rim/efeitos dos fármacos , Peroxidação de Lipídeos , Fígado/efeitos dos fármacos , Masculino , Estresse Oxidativo , Ratos , Ratos Wistar , Selênio/sangue , Zinco/metabolismo
11.
Exp Toxicol Pathol ; 63(5): 491-8, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20385473

RESUMO

The aim of this study was to evaluate whether zinc (Zn) supplementation can protect from an enhanced risk of femoral neck fracture due to chronic exposure to cadmium (Cd). For this purpose, biomechanical properties of the neck and bone mineral density (BMD) at the proximal femur of rats receiving Cd (5 or 50mg/l) or/and Zn (30 or 60 mg/l) in drinking water for 6 and 12 months were evaluated. The exposure to 5 and 50mg Cd/l decreased the proximal femur BMD and affected biomechanical properties of the femoral neck. In the rats treated with 5mg Cd/l, weakening of the femoral neck strength was observed after 12 months, whereas at higher exposure--already after 6 months. The supplementation with 30 and 60 mg Zn/l, enhancing its daily intake by 68% and 138%, respectively, compared to the standard diet, had beneficial influence on the femoral neck biomechanical properties during the exposure to Cd, but it had no impact on the proximal femur BMD. Zn administration during the 12-month exposure to 5mg Cd/l totally prevented the weakening of the neck. Zn supplementation during the 6-month treatment with 50mg Cd/l entirely prevented the Cd-induced decrease in the neck fracture strength; however, at the longer exposure to Cd the protective effect of Zn was only partial. The beneficial Zn influence was independent on its dose. The results allow the conclusion that an increase in the daily intake of Zn during moderate and relatively high exposures to Cd can reduce femoral neck susceptibility to fracture. Based on the findings, it seems that enhanced Zn consumption in subjects chronically exposed to Cd may, at least partly, protect from the enhanced risk of femoral neck fracture.


Assuntos
Cloreto de Cádmio/toxicidade , Suplementos Nutricionais , Poluentes Ambientais/toxicidade , Fraturas do Colo Femoral/prevenção & controle , Colo do Fêmur/efeitos dos fármacos , Zinco/uso terapêutico , Animais , Densidade Óssea/efeitos dos fármacos , Cloreto de Cádmio/sangue , Cloreto de Cádmio/farmacocinética , Poluentes Ambientais/farmacocinética , Fraturas do Colo Femoral/metabolismo , Colo do Fêmur/diagnóstico por imagem , Colo do Fêmur/metabolismo , Masculino , Radiografia , Ratos , Ratos Wistar , Risco , Fatores de Tempo , Zinco/administração & dosagem , Zinco/farmacologia
12.
Chem Biol Interact ; 177(2): 142-52, 2009 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-18848534

RESUMO

It has been investigated, based on a rat model of human exposure to cadmium (Cd), whether zinc (Zn) supplementation may prevent Cd-induced alterations in lipid metabolism. For this purpose, the concentrations of free fatty acids (FFA), phospholipids (PL), triglycerides (TG), total cholesterol (TCh), and high and low density lipoprotein cholesterol (HDL and LDL, respectively) as well as the concentrations of chosen indices of lipid peroxidation such as lipid peroxides (LPO), F2-isoprostane (F2-IsoP) and oxidized LDL (oxLDL) were estimated in the serum of male Wistar rats administered Cd (5 or 50mg/l) or/and Zn (30 or 60mg/l) in drinking water for 6 months. The exposure to 5 and 50mg Cd/l resulted in marked alterations in the lipid status reflected in increased concentrations of FFA, TCh, LDL, LPO, F2-IsoP and oxLDL, and decreased concentrations of PL and HDL in the serum. The concentrations of LDL, LPO, F2-IsoP and oxLDL were more markedly enhanced at the higher Cd dosage. The supplementation with Zn during the exposure to 5 and 50mg Cd/l entirely prevented all the Cd-induced changes in the serum concentrations of the estimated lipid compounds and indices of lipid peroxidation, except for the F2-IsoP for which Zn provided only partial protection. Based on the results it can be concluded that Zn supplementation during exposure to Cd may have a protective effect on lipid metabolism consisting in its ability to prevent hyperlipidemia, including especially hypercholesterolemia, and to protect from lipid peroxidation. The findings seem to suggest that enhanced dietary Zn intake during Cd exposure, via preventing alterations in the body status of lipids may, at least partly, protect against some effects of Cd toxicity, including oxidative damage to the cellular membranes and atherogenic action. The paper is the first report suggesting protective impact of Zn against proatherogenic Cd action on experimental model of chronic moderate and relatively high human exposure to this toxic metal.


Assuntos
Cloreto de Cádmio/toxicidade , Cloretos/administração & dosagem , Substâncias Perigosas/toxicidade , Metabolismo dos Lipídeos/efeitos dos fármacos , Peroxidação de Lipídeos/efeitos dos fármacos , Compostos de Zinco/administração & dosagem , Animais , Quimioprevenção , Colesterol/sangue , Suplementos Nutricionais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Ingestão de Líquidos , Quimioterapia Combinada , Ácidos Graxos não Esterificados/sangue , Hiperlipidemias/induzido quimicamente , Hiperlipidemias/metabolismo , Hiperlipidemias/prevenção & controle , Rim/química , Rim/efeitos dos fármacos , Rim/metabolismo , Peroxidação de Lipídeos/fisiologia , Masculino , Fosfolipídeos/sangue , Ratos , Ratos Wistar , Triglicerídeos/sangue
13.
Chem Biol Interact ; 171(3): 312-24, 2008 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-18164699

RESUMO

The present study was aimed at estimate, based on the rat model of human moderate and relatively high chronic exposure to cadmium (Cd), whether zinc (Zn) supplementation may prevent Cd-induced weakening in the bone biomechanical properties. For this purpose, male Wistar rats were administered Cd (5 or 50 mg/l) or/and Zn (30 or 60 mg/l) in drinking water for 6 and 12 months. Bone mineral density (BMD) and biomechanical properties (yield load, ultimate load, post-yield load, displacement at yield and at ultimate, stiffness, work to fracture, yield stress, ultimate stress and Young modulus of elasticity) of the femoral distal end and femoral diaphysis were examined. Biomechanical properties of the distal femur were estimated in a compression test, whereas those of the femoral diaphysis -- in a three-point bending test. Exposure to Cd, in a dose and duration dependent manner, decreased the BMD and weakened the biomechanical properties of the femur at its distal end and diaphysis. Zn supplementation during Cd exposure partly, but importantly, prevented the weakening in the bone biomechanical properties. The favorable Zn influence seemed to result from an independent action of this bioelement and its interaction with Cd. However, Zn supply at the exposure to Cd had no statistically significant influence on the BMD at the distal end and diaphysis of the femur. The results of the present paper suggest that Zn supplementation during exposure to Cd may have a protective influence on the bone tissue biomechanical properties, and in this way it can, at least partly, decrease the risk of bone fractures. The findings seem to indicate that enhanced dietary Zn intake may be beneficial for the skeleton in subjects chronically exposed to Cd.


Assuntos
Cádmio/toxicidade , Diáfises/efeitos dos fármacos , Suplementos Nutricionais , Fêmur/efeitos dos fármacos , Zinco/administração & dosagem , Absorciometria de Fóton , Administração Oral , Animais , Fenômenos Biomecânicos , Densidade Óssea/efeitos dos fármacos , Cádmio/antagonistas & inibidores , Diáfises/diagnóstico por imagem , Diáfises/metabolismo , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Fêmur/diagnóstico por imagem , Fêmur/metabolismo , Masculino , Ratos , Ratos Wistar
14.
Toxicology ; 237(1-3): 89-103, 2007 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-17560002

RESUMO

The aim of the present study is to investigate, based on the rat model of moderate and relatively high human exposure to cadmium (Cd), whether zinc (Zn) supplementation may prevent Cd-induced disorders in bone metabolism. For this purpose, male Wistar rats received Cd (5 and 50mg/l) or/and Zn (30 and 60mg/l) in drinking water for 6 and 12 months. Bone densitometry and biochemical markers of bone turnover were used to assess the effects of Cd or/and Zn. Bone mineral content (BMC) and density (BMD) were measured in the femur. Serum osteocalcin (OC) and alkaline phosphatase in trabecular (bT-ALP) and cortical (bC-ALP) bone were determined as bone formation markers, and carboxy-terminal cross-linking telopeptides of type I collagen (CTX) in serum were measured as bone resorption marker. Serum concentration of calcium (Ca) and its renal handling, as well as Zn and Cd concentrations in the serum/blood, urine and femur were evaluated as well. The exposure to 5 and 50mg Cd/l (0.340+/-0.026 and 2.498+/-0.093mg Cd/kg body wt/24h, respectively), in a dose and duration dependent manner, affected bone turnover (inhibited bone formation and stimulated its resorption) and disturbed bone mineralization (decreased BMC, BMD and Zn concentration). Zn supply at the concentration of 30 and 60mg/l (1.904+/-0.123 and 3.699+/-0.213mg/kg body wt/24h, respectively) during Cd exposure influenced the Cd-induced disorders in bone metabolism. Zn administration to the Cd-exposed rats enhanced the bone ALP activity and prevented Cd-induced bone resorption, but had no statistically significant effect on BMC and BMD; however, mean values of the densitometric parameters in the rats receiving both Cd and Zn were higher than in those treated with Cd alone. Moreover, Zn supplementation at both levels of Cd exposure was found to prevent Cd accumulation in the femur and the Cd-induced decrease in bone Zn concentration. The results of the present study allow the conclusion that Zn supplementation during Cd exposure may partly protect from disorders in bone metabolism. The influence of Zn may be accompanied by its ability to prevent Cd-induced Zn deficiency and to decrease Cd accumulation in bone tissue. The findings seem to indicate that enhanced dietary intake of Zn in subjects chronically exposed to moderate and relatively high Cd levels may have a protective influence on the skeleton.


Assuntos
Reabsorção Óssea , Osso e Ossos/metabolismo , Cloreto de Cádmio/toxicidade , Cloretos , Compostos de Zinco , Absorciometria de Fóton , Animais , Peso Corporal/efeitos dos fármacos , Densidade Óssea/efeitos dos fármacos , Reabsorção Óssea/induzido quimicamente , Reabsorção Óssea/metabolismo , Reabsorção Óssea/prevenção & controle , Osso e Ossos/efeitos dos fármacos , Cloreto de Cádmio/farmacocinética , Cálcio/sangue , Cloretos/administração & dosagem , Cloretos/farmacocinética , Cloretos/farmacologia , Cloretos/uso terapêutico , Colágeno Tipo I/sangue , Interações Medicamentosas , Fêmur/efeitos dos fármacos , Fêmur/metabolismo , Masculino , Osteocalcina/sangue , Peptídeos/sangue , Ratos , Ratos Wistar , Compostos de Zinco/administração & dosagem , Compostos de Zinco/farmacocinética , Compostos de Zinco/farmacologia , Compostos de Zinco/uso terapêutico
15.
Przegl Lek ; 61(4): 348-50, 2004.
Artigo em Polonês | MEDLINE | ID: mdl-15521599

RESUMO

Cigarette smoke contains about 4000 chemical substances, including toxic metals such as cadmium. Smoking of 20 cigarettes a day results in inhalation an average 3.6-6.0 microg of cadmium. Due to nephrotoxic action of some components of tobacco smoke, and especially cadmium, the present study was aimed to evaluate of chosen parameters of kidney status in cigarette smokers in connection with estimation of cadmium concentration. The study was conducted in eighty-nine health and unexposed occupationally to cadmium inhabitants of Bialystok, smoking and non-smoking men and women at age 35-50. The smokers consumed 20 and more cigarettes per day for longer period than 10 years. Blood and morning urine were collected for analysis. In the urine samples, cadmium concentration (by atomic absorption spectrometry) and cotinine concentration (by gas chromatography with mass spectrometry), as an indicator of exposure to cigarette smoke, were determined. The kidney status was evaluated based on the urinary activities of lysosomal enzyme N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B (by colourimetrical method modified by Zwierz et al.) and concentrations of creatinine and urea in the serum (using diagnostic laboratory tests by POCh). The percentage reabsorption of phosphates was evaluated as well (TRP). Cadmium concentration in the urine of smoking women and men was higher compared to non-smokers, but there was no correlation between cadmium and cotinine concentrations in urine. In the smoking women, the urinary activity of NAG and TRP were higher than in non-smoking ones. In smokers, the activities of NAG and NAG-B in men and the activity of NAG-B in women were in the range of values noted in non-smokers, however the frequency of appearance of NAG and NAG-B activities above the limit of detection was higher compared to non-smokers. Cigarette smoking had no influence on the serum concentrations of creatinine and urea in both men and women and TRP in men. The results of the analysis of the urinary NAG and NAG-B activities in conjunction with the frequency of their appearance allow concluding that cigarette smoke might lead to an occurrence of early changes in proximal tubules of men and women.


Assuntos
Cádmio/urina , Rim/efeitos dos fármacos , Rim/metabolismo , Fumar/sangue , Fumar/urina , Acetilglucosaminidase/urina , Adulto , Cádmio/efeitos adversos , Cádmio/sangue , Estudos de Casos e Controles , Cotinina/urina , Creatinina/sangue , Feminino , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Masculino , Pessoa de Meia-Idade , Polônia , Espectrofotometria Atômica , Fatores de Tempo , Ureia/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...